Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-05 Sale(A) |
2020-08-10 4:03 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $20 | $267,480 | 147,125 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 5:44 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $20 | $265,480 | 147,225 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:51 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $20 | $132,530 | 304,074 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 12:27 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:00 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-03-29 4:13 pm |
N/A 2032-02-08 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
76,667 | $0 | 76,667 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:43 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-08-05 Exercise(A) |
2020-08-10 4:03 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $7.5 | 147,125 (Direct) |
View |
| 2020-08-05 Exercise(A) |
2020-08-10 4:03 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $0 | 147,125 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $7.5 | 147,225 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:44 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $0 | 147,225 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $7.5 | 304,074 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $0 | 304,074 (Direct) |
View |